Major Depression in the National Comorbidity Survey - Adolescent Supplement: Prevalence, Correlates, and Treatment
Washington D.C., January 6, 2015
A recent study published in the January 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry underscores the important public health significance of depression among U.S. adolescents.
Mental disorders are the leading cause of years lived with disability worldwide with 40.5% of this burden attributable to major depression. In adolescence, rates of depression increase substantially between 13 and 18 years of age, and the estimated cumulative incidence in this population approximates the adult lifetime prevalence rate.
Using data from a nationally representative sample of adolescents who participated in the National Comorbidity Survey - Adolescent Supplement (NCS-A), a group of researchers led by Dr. Kathleen Merikangas of the National Institute of Mental Health's Intramural Research Program, evaluated symptoms of DSM-IV major depressive disorder (MDD), mild/moderate MDD, and severe MDD in 10,123 adolescents. Data was collected from adolescents 13 to 18 years old, representing the critical developmental period for the onset of depression.
MDD was highly prevalent in adolescents, whether measured over lifetime (11%) or past year (7.5%). Prevalence rates of MDD increased across adolescence, and females had 2-3-fold greater rates than males. The majority of adolescents with MDD demonstrated severe role impairment and substantial comorbidity with other mental conditions. Although treatment in any form was received by the majority of adolescents with MDD (60.4%), a much lower percentage received disorder-specific treatment (33.9%) or received treatment from the mental health sector (34.9%).
"One of the major concerns raised by these findings was the substantial proportion of those with severe major depression who reported a history of suicide attempts, yet many had not received care in either the medical or mental health sectors," said Dr. Shelli Avenevoli, the lead author, who was involved in the development of the NCS-A.
These findings extend the growing evidence regarding the significance of adolescent depression from regional community studies1, and national surveys that focused on current depressive episodes in adolescents2,3.The study highlights the clinical and public health need for screening, early identification, early intervention and treatment of MDD during adolescence.
- Copeland WE, Shanahan L, Costello EJ, Angold A. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry. 2009 Jul; 66(7):764-72.
- 2. Results from the 2013 National Survey on Drug Use and Health: National Findings.SAMHSA.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf.
- Merikangas KM, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among U.S. children in the 2001-2004 NHANES. Pediatrics. Jan 2010; 125(1):75-81.
The article "Major Depression in the National Comorbidity Survey–Adolescent Supplement: Prevalence, Correlates, and Treatment" by Shelli Avenevoli, Joel Swendsen, Jian-Ping He, Marcy Burstein, Kathleen Ries Merikangas, (http://dx.doi.org/10.1016/j.jaac.2014.10.010) appears in the Journal of the American Academy of Child and Adolescent Psychiatry, Volume 54, Issue 1 (January 2015), published by Elsevier.
This study was supported by the Intramural Research Program of NIMH (1 ZIA MH002808). The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or US government.
Notes for editors
Full text of the article is available to credentialed journalists upon request; contact Mary Billingsley at +1 202 587 9672 or firstname.lastname@example.org. Journalists wishing to interview the authors may contact the NIMH Media Office at NIMHpress@mail.nih.gov.
All articles published in JAACAP are embargoed until the day they are published as in press corrected proofs online at http://jaacap.org/inpress. Articles cannot be publicized as in press accepted manuscripts. Contents of the publication should not be released to or by the media or government agencies prior to the embargo date.
Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families. www.jaacap.com
The journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.
Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 38,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
JAACAP Editorial Office
+1 202 587 9672